Advance medicine for the benefit of patients with psoriasis

According to the prevalence of this condition, in adults it is estimated that it is from 1 to 3% y, according to Dr. Francisco in the child population increases only by 0.5%, which is not common.

Dr. Francisco Colón, Pediatric Dermatologist.
Dr. Francisco Colón, Pediatric Dermatologist.

Agencia Latina de Noticias Medicina y Salud Pública

Although the psoriasis continues to cure, the investigations have progressed rapidly, and the population is currently taking effective medications and ensures that the condition can be monitored at the point of total admission.

“It has significantly advanced in terms of the pathophysiology of psoriasis, lasting 15 years, obtaining a good amount of medication”, said the speeches of the pediatric dermatologist, Dr. Francisco Colón, for the Journal of Medicine and Public Health (MSP).

In addition, there are advances in medications, the specialist said, while dermatologists have the most knowledge of this chronic inflammatory disease, recording a temperament diagnosis, and its more effective treatments.

The basic treatment for psoriasis is based on topical corticosteroids, in addition to the use of vitamin D derivatives, such as calcipotriene. If you can use phototherapy with ultraviolet B short band, and if it does not work, we start treatment with oral drugs “, said the Dr. Colon, who adheres to the study of medicines and treatments for this disease is realized beforehand, when approved, is used in the pediatric edema.

Among other things, Francisco Colón, also a cathedrator associated with the Department of Dermatology at the School of Medicine of the University of Puerto Rico, stated: “It is clear that psoriasis in general is a dysregulation of cellulite in the immunological system. Although the causes, there are many theories, without embarrassment, there are some specific cells between the types T 1 and 17, which are hyperreactive and produce mediators of inflammation, called intermittent.

It is important to note that psoriasis is not only central to the skin, but also, cardiovascular and psychological risks, because it is also important to treat patients with drugs that are extremely safe and effective. which, I do not want an organ specifically.

This inflammatory cutaneous disease can be associated with psoriatic arthritis, both in adults as in children, without embarrassment, the dermatologist Colon explains that, it is more common that the children debilitated in psoriasis with arthritis.

Agreed with a publication of Redacción Médica, are now developing new study visas to continue advancing in therapy, with constant investigation in molecular clinics, as for example, anti IL 23 and IL-17, are approved in the pediatric population, among others. As such, it is investigating the impact on the quality of life, and on the detection of patients’ preferences, treating situational in the center of their illness.

Today there are safe pharmacies, with very adequate results and that allow patients to increase a degree of satisfaction raised with their treatment, achieving full form of the physical, psychic and quality of life aspects.

The incidence of psoriasis in the pediatric population is 0.5%

According to the prevalence of this condition, in adults it is estimated that it is from 1 to 3% y, according to Dr. Francisco in the child population increases only by 0.5%, which is not common.

“It can be debated that there is a difficulty in recognizing this condition in the pediatric edema and that it can be associated with other diseases such as atopic dermatitis or seborrhea. Hecho, it is estimated that a third part of the adult patients can attest that tuvieron lesions appear in the psoriasis, but can never receive the diagnostic.

“Without embarrassment, it can be said that there is more education about this being carried out by those who carry out the diagnostics immediately,” he explained.

There are no known infections that can unmask a genetic predisposition to develop this condition, for example, having a bacterial infection that has the potential to produce psoriasis. Meanwhile, as it is known, the cause is that it is transmitted to one person and to another.

The galen insists that one of the factors of risk for the development of psoriasis is the immunological, genetic and ambient as for example stress, diet, and toxic habits.

Currently, in the United States there are three biological medicines that are injected into the subcutaneous form, approved for pediatric patients, the blocks are interlaced.